Open Label Extension Study of Brentuximab Vedotin in Early dcSSc
An Open Label Extension Study of Brentuximab Vedotin Treatment in Active Diffuse Cutaneous Systemic Sclerosis (Diffuse Scleroderma) An Open Label Extension Study of BrentuximabVedotin Treatment in Active Diffuse Cutaneous Systemic S ...
Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis
A Pilot Study of Adcetris Treatment in Active Diffuse Cutaneous Systemic Sclerosis (Diffuse Scleroderma) A Pilot Study of Adcetris Treatment in Active Diffuse Cutaneous Systemic Sclerosis (Diffuse Sclerode ...
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI) Evaluation of BrentuximabVedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multic ...